Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-13

FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Supplemental Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ScieGen Pharmaceuticals' supplemental application for a sustained-release generic version of bupropion hydrochloride, with the same indications as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride sustained-release (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (SR) (BUPROPION HYDROCHLORIDE)